Detalles de la búsqueda
1.
Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
Br J Surg
; 111(4)2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38608150
2.
New EAU/ASCO guideline recommendations on sentinel node biopsy for penile cancer and remaining challenges from a nuclear medicine perspective.
Eur J Nucl Med Mol Imaging
; 2024 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38216778
3.
The accuracy and intra- and interobserver variability of PSMA PET/CT for the local staging of primary prostate cancer.
Eur J Nucl Med Mol Imaging
; 51(6): 1741-1752, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38273003
4.
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.
BJU Int
; 133 Suppl 4: 14-22, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37858931
5.
99m TcPSMA-radioguided surgery in oligorecurrent prostate cancer: the randomised TRACE-II trial.
BJU Int
; 2024 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38346924
6.
A hybrid radioactive and fluorescence approach is more than the sum of its parts; outcome of a phase II randomized sentinel node trial in prostate cancer patients.
Eur J Nucl Med Mol Imaging
; 50(9): 2861-2871, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37036490
7.
The prognostic value of lymph node staging with prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and extended pelvic lymph node dissection in node-positive patients with prostate cancer.
BJU Int
; 131(3): 330-338, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36069585
8.
Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.
BJU Int
; 132(6): 705-712, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37620288
9.
Incidence of PSMA PET thyroid incidentaloma depends on analysis method and tracer.
Eur Radiol
; 33(5): 3377-3385, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36892644
10.
The impact of drainage pathways on the detection of nodal metastases in prostate cancer: a phase II randomized comparison of intratumoral vs intraprostatic tracer injection for sentinel node detection.
Eur J Nucl Med Mol Imaging
; 49(5): 1743-1753, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34748059
11.
Retrospective analysis of PSMA PET/CT thyroid incidental uptake in adults: incidence, diagnosis, and treatment/outcome in a tertiary cancer referral center and University Medical Center.
Eur J Nucl Med Mol Imaging
; 49(7): 2392-2400, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35031811
12.
Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging.
BJU Int
; 129(1): 54-62, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34028165
13.
Incidence and risk factor analysis of complications after sentinel node biopsy for penile cancer.
BJU Int
; 130(4): 486-495, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35257463
14.
Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography/computed tomography is associated with oncological outcomes in patients with prostate cancer.
BJU Int
; 129(6): 768-776, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35166426
15.
The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer.
J Urol
; 205(6): 1655-1662, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33530746
16.
Management impact of 18F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study.
Eur J Nucl Med Mol Imaging
; 48(9): 2960-2969, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33547552
17.
Clinical response assessment on DW-MRI compared with FDG-PET/CT after neoadjuvant chemoradiotherapy in patients with oesophageal cancer.
Eur J Nucl Med Mol Imaging
; 48(1): 176-185, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32572560
18.
Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study.
BMC Cancer
; 20(1): 723, 2020 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32758168
19.
Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.
BJU Int
; 125(2): 206-214, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31680398
20.
Where to next prostate-specific membrane antigen PET imaging frontiers?
Curr Opin Urol
; 30(5): 672-678, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32701718